Back to Startups

Suzhou Ribo Life Science

About Suzhou Ribo Life Science

Ribo is a biotech company focused on developing siRNA therapies, with dedicated R&D centers aimed at advancing innovative treatments.

Business Information
Target Customers
pharmaceutical companies research institutions healthcare providers
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model B2B partnerships and collaborations
Pricing Strategy Project-based pricing and licensing agreements
Sales Channels direct sales, partnerships with pharmaceutical companies
Funding Timeline
Round Date Amount Investors
Series E Jul 21, 2025 $28.0M Mingxin Capital
Founders

No founder information available.

Investors
M
Mingxin Capital

Venture Capital

Recent Mentions
chuminhua432
Minhua Chu @chuminhua432
Jul 21, 2025

🇨🇳 Suzhou Ribo Life Science announced the successful completion of its Series E #financing round, raising over RMB 200 million (approximately $28 million). The round was led by Mingxin Capital. https://t.co/Ax3WK1oqhk Ribo is a biotech focus on #siRNA therapies with R&D centers https://t.co/40cs0JtEWF